Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 672.00
+4.00 (0.60%)
Jan 22, 2026, 4:29 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 40.36 million as of January 22, 2026. Its market cap has increased by 185.24% in one year.
Market Cap
40.36M
Enterprise Value
42.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
672.00
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 40.36M, an increase of 277.82%. That is a compound annual growth rate of 17.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 41.14M | 19.06% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 94.05M |
| 4basebio | 91.32M |
| SkinBioTherapeutics | 48.52M |
| hVIVO | 37.76M |
| Ondine Biomedical | 35.54M |
| ImmuPharma | 34.69M |
| Poolbeg Pharma | 32.42M |
| Arecor Therapeutics | 31.15M |